Goldman Sachs Group »

Sagimet Biosciences Inc-a shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $161k 30k 5.42
2023-09-30 $173k 20k 8.80

More positions owned by Goldman Sachs Group

Spdr S&p 500 Etf Tr CMN (SPY)
Microsoft Corp CMN (MSFT)
Nvidia Corporation CMN (NVDA)
Apple CMN (AAPL)
Amazon CMN (AMZN)
Ishares Tr CMN (IWM)
Ishares Tr CMN (IVV)
Invesco Qqq Tr CMN (QQQ)
Meta Platforms CMN (META)
Alphabet CMN (GOOGL)
Vanguard Index Fds CMN (VOO)
Tesla CMN (TSLA)
Visa CMN (V)
Ishares Tr CMN (HYG)
Ishares Tr CMN (EFA)

View all positions for Goldman Sachs Group

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rtw Investments
Partner Fund Management
Rock Springs Capital Management
Hillhouse Capital Advisors
Artal Group
Millennium Management
Renaissance Technologies

View all funds holding Sagimet Biosciences Inc-a